AAAAAA

   
Results: 1-9 |
Results: 9
Pre-clinical evaluation of a methotrexate-albumin conjugate (MTX-HSA) in human tumor xenografts in vivo
Authors: Burger, AM Hartung, G Stehle, G Sinn, H Fiebig, HH
Citation: Am. Burger et al., Pre-clinical evaluation of a methotrexate-albumin conjugate (MTX-HSA) in human tumor xenografts in vivo, INT J CANC, 92(5), 2001, pp. 718-724
Adaptation and clinical evaluation of a homogenous enzyme multiplied immunoassay technique (EMIT) for drug monitoring of a methotrexate-albumin conjugate (MTX-HSA) in humans
Authors: Hartung, G Heeger, S Bertsch, T Frei, E Wunder, A Kranzle, M Stehle, G Weigand, M Schrenk, HH Sinn, H Queisser, W
Citation: G. Hartung et al., Adaptation and clinical evaluation of a homogenous enzyme multiplied immunoassay technique (EMIT) for drug monitoring of a methotrexate-albumin conjugate (MTX-HSA) in humans, ONKOLOGIE, 23(4), 2000, pp. 352-357
Is albumin administration harmful in critically ill patients? The patient's nitrogen and energy balance may provide an answer
Authors: Stehle, G Wunder, A Heene, DL
Citation: G. Stehle et al., Is albumin administration harmful in critically ill patients? The patient's nitrogen and energy balance may provide an answer, CRIT CARE M, 28(5), 2000, pp. 1697-1697
Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients
Authors: Hartung, G Stehle, G Sinn, H Wunder, A Schrenk, HH Heeger, S Kranzle, M Edler, L Frei, E Fiebig, HH Heene, DL Maier-Borst, W Queisser, W
Citation: G. Hartung et al., Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients, CLIN CANC R, 5(4), 1999, pp. 753-759
Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate
Authors: Stehle, G Wunder, A Schrenk, HH Hartung, G Heene, DL Sinn, H
Citation: G. Stehle et al., Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate, ANTI-CANC D, 10(8), 1999, pp. 785-790
Methotrexate-albumin conjugate causes tumor growth delay in Dunning R3327 HI prostate cancer-bearing rats
Authors: Stehle, G Wunder, A Schrenk, HH Hartung, G Heene, DL Sinn, H
Citation: G. Stehle et al., Methotrexate-albumin conjugate causes tumor growth delay in Dunning R3327 HI prostate cancer-bearing rats, ANTI-CANC D, 10(4), 1999, pp. 405-411
Catabolic consequences of infection and injury: The role of plasma protein(albumin) loss
Authors: Stehle, G Wunder, A
Citation: G. Stehle et A. Wunder, Catabolic consequences of infection and injury: The role of plasma protein(albumin) loss, J PARENT EN, 23(2), 1999, pp. 114-115
Direct convective macromolecule delivery
Authors: Stehle, G Heene, DL Wunder, A Schrenk, HH Sinn, H
Citation: G. Stehle et al., Direct convective macromolecule delivery, J NEUROSURG, 90(3), 1999, pp. 610-611
Prognostic value of cathepsin D in breast cancer
Authors: Stehle, G Wunder, A Hartung, G Sinn, H Heene, DL
Citation: G. Stehle et al., Prognostic value of cathepsin D in breast cancer, BR J CANC, 81(8), 1999, pp. 1427-1428
Risultati: 1-9 |